BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 8725564)

  • 21. Pathogenesis of experimental gastric-mucosal injury.
    Kivilaakso E; Silen W
    N Engl J Med; 1979 Aug; 301(7):364-9. PubMed ID: 37443
    [No Abstract]   [Full Text] [Related]  

  • 22. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?
    Dajani EZ
    Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566
    [No Abstract]   [Full Text] [Related]  

  • 24. Nitric oxide-releasing aspirin protects gastric mucosa against ethanol damage in rats with functional ablation of sensory nerves.
    Konturek PC; Brzozowski T; Kania J; Konturek SJ; Hahn EG
    Inflamm Res; 2003 Sep; 52(9):359-65. PubMed ID: 14504662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Mouriri pusa extracts on experimentally induced gastric lesions in rodents: role of endogenous sulfhydryls compounds and nitric oxide in gastroprotection.
    Andreo MA; Ballesteros KV; Hiruma-Lima CA; Machado da Rocha LR; Souza Brito AR; Vilegas W
    J Ethnopharmacol; 2006 Oct; 107(3):431-41. PubMed ID: 16698206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nitric oxide in indomethacin-induced gastric mucosal dysfunction in the rat.
    Gürbüz V; Alican I; Berrak ; Yegen C; Bozkurt A; Oktar B; Haklar G; Yüksel M; Kurtel H
    Exp Physiol; 1999 Mar; 84(2):319-32. PubMed ID: 10226173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on pathogenesis of gastric ulcer in patient with liver cirrhosis: with special reference to the gastric mucosal blood flow].
    Maeda T
    Fukuoka Igaku Zasshi; 1988 Aug; 79(8):636-46. PubMed ID: 3192152
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy.
    Whittle BJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S43-7. PubMed ID: 10379469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prostaglandins in gastroprotection and gastric adaptation.
    Brzozowski T; Konturek PC; Konturek SJ; Brzozowska I; Pawlik T
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():33-55. PubMed ID: 16247188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Prostaglandins and stress ulcer.
    Wilson DE
    Prostaglandins; 1974 Oct; 8(1):52-3. PubMed ID: 4457959
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of afferent sensory neurones in gastric injury/protection.
    Rybárová S; Kocisová M; Mirossay L
    Physiol Res; 1994; 43(6):347-54. PubMed ID: 7540865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular and molecular mechanisms of the gastric mucosa: injury of the mucosa and the protective action of antacids].
    Tarnawski A
    Rev Gastroenterol Peru; 1995; 15(1):74-8. PubMed ID: 7537548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of nitric oxide on the regulation of gastric blood flow].
    Calatayud S; Beltrán B; Moreno L; Martínez-Cuesta MA; Esplugues JV
    Gastroenterol Hepatol; 1997 May; 20 Suppl 2():33-6. PubMed ID: 9254250
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostaglandins--role in gastric mucosal cytoprotection.
    Sewell RB
    Med J Aust; 1985 Feb; 142 Spec No():S10-3. PubMed ID: 3937961
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat.
    Robert A; Nezamis JE; Phillips JP
    Gastroenterology; 1968 Oct; 55(4):481-7. PubMed ID: 5698627
    [No Abstract]   [Full Text] [Related]  

  • 36. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacological bases of non-steroidal anti-inflammatory analgesics].
    Beltrán B; Moreno L; Esplugues JV
    Gastroenterol Hepatol; 1996 Nov; 19(9):478-88. PubMed ID: 8998674
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.
    Takeuchi K; Ukawa H; Konaka A; Kitamura M; Sugawa Y
    J Pharmacol Exp Ther; 1998 Jul; 286(1):115-21. PubMed ID: 9655849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central and peripheral neural aspects of gastroprotective and ulcer healing effects of lipopolysaccharides.
    Konturek PC; Brzozowski T; Meixner H; Ptak A; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):611-23. PubMed ID: 11787762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in gastric mucosa: an important component of gastric erosion and ulcer healing and its impairment in aging.
    Tarnawski AS; Ahluwalia A; Jones MK
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():112-23. PubMed ID: 25521743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.